A prospective, randomized multicenter, open-label, safety and preliminary efficacy study of Immunotherapy in patients with unresectable hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE)
Latest Information Update: 18 Sep 2019
At a glance
- Drugs Dendritic cell vaccine-CreaGene (Primary) ; Cyclophosphamide
- Indications Liver cancer
- Focus Therapeutic Use
- Acronyms IMMANUEL
- Sponsors JW CreaGene
- 16 Feb 2014 New trial record